October 2018 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- From Big To Specialty — The Operational Transformation Of Bristol-Myers Squibb
- Apellis Advances On Autoimmunity
- Bayer Corrals U.S. Bio Clusters On Both Coasts
Capitol Perspectives
Patient Perspectives
CEO Corner
From Principles and Policy to Execution
Industry Research
Companies To Watch
Inside The Industry
- Improving Diversity in Life Sciences: 4 Ways to Turn Outrage into Action
- Lessons Learned from A Biopharma Cybersecurity Attack
- Biopharma Pioneer Returns To Small Company Roots
- Serendipity: When Funders Found A Company
- What To Consider When Crafting Biotech NDAs
- Preparing A Promising Drug Candidate For ANDA Litigation (Part Two)
Leadership Lessons
Ask The Board
- How Do You Build A System At A Life Sciences Company That Is “Fit For Purpose”?
- How Can We Get Away From Blaming Human Error Or Training During The RCA (Root Cause Analysis) Process Of CAPA (Corrective And Preventative Action) And Instead Get To The True Root Of The Issue?
- What Are The Current Trends For Where Compliance Reports In Small To Midsize Life Sciences Companies?
This website uses cookies to ensure you get the best experience on our website. Learn more